Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Klaus Mönkemüller is active.

Publication


Featured researches published by Klaus Mönkemüller.


Gastroenterology | 2015

SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Loren Laine; Tonya Kaltenbach; Alan N. Barkun; Kenneth R. McQuaid; Venkataraman Subramanian; Roy Soetikno; James E. East; Francis A. Farraye; Brian G. Feagan; John P. A. Ioannidis; Ralf Kiesslich; Michael J. Krier; Takayuki Matsumoto; Robert P. McCabe; Klaus Mönkemüller; Robert D. Odze; Michael F. Picco; David T. Rubin; Michele Rubin; Carlos A. Rubio; Matthew D. Rutter; Andres Sanchez-Yague; Silvia Sanduleanu; Amandeep K. Shergill; Thomas A. Ullman; Fernando S. Velayos; Douglas Yakich; Yu-Xiao Yang

Patients with ulcerative colitis or Crohn’s colitis have an increased risk of colorectal cancer (CRC). Most cases are believed to arise from dysplasia, and surveillance colonoscopy therefore is recommended to detect dysplasia. Detection of dysplasia traditionally has relied on both examination of the mucosa with targeted biopsies of visible lesions and extensive random biopsies to identify invisible dysplasia. Current U.S. guidelines recommend obtaining at least 32 random biopsy specimens from all segments of the colon as the foundation of endoscopic surveillance. However, much of the evidence that provides a basis for these recommendations is from older literature, when most dysplasia was diagnosed on random biopsies of colon mucosa. With the advent of video endoscopy and newer endoscopic technologies, investigators now report that most dysplasia discovered in patients with inflammatory bowel disease (IBD) is visible. Such a paradigm shift may have important implications for the surveillance and management of dysplasia. The evolving evidence regarding newer endoscopic methods to detect dysplasia has resulted in variation among guideline recommendations from organizations around the world. We therefore sought to develop unifying consensus recommendations addressing 2 issues: (1) How should surveillance colonoscopy for detection of dysplasia be performed? (2) How should dysplasia identified at colonoscopy be managed?


The American Journal of Gastroenterology | 2010

Prospective Multicenter Trial Comparing Push-and-Pull Enteroscopy With the Single- and Double-Balloon Techniques in Patients With Small-Bowel Disorders

Andrea May; Michael Färber; Insa Aschmoneit; Jürgen Pohl; Hendrik Manner; Erich Lotterer; Oliver Möschler; J Kunz; Liebwin Gossner; Klaus Mönkemüller; C. Ell

OBJECTIVES:Double-balloon enteroscopy (DBE) is now an established method for diagnostic and therapeutic small-bowel endoscopy. Single-balloon enteroscopy (SBE) has been introduced to simplify the technique. A prospective randomized study was carried out to compare the two methods.METHODS:The study included 100 patients (50 in each group; 63 men, 37 women; mean age 55 years), with no previous small-bowel or colon surgery. The indications for enteroscopy were (suspected) mid-gastrointestinal bleeding, Crohns disease, small-bowel masses, chronic diarrhea or abdominal pain or both, and other conditions. Fujinon instruments were used, with either two balloons or one. The end point of the study was complete enteroscopy as the most objective parameter.RESULTS:No severe complications such as perforation, bleeding, or pancreatitis occurred. Instrument preparation time was significantly faster with SBE than with DBE (P<0.0001). Complete enteroscopy was achieved with the DBE technique in 66% of cases (33 patients), either with the oral route alone or with combined oral and anal approaches. With the SBE technique, the complete enteroscopy rate was significantly lower at 22% (P<0.0001; 11 patients, only with oral and anal routes combined). The rate of therapeutic consequences for the patients based on diagnostic yield and negative complete enteroscopy was significantly higher (P=0.025) in the DBE group at 72%, compared with 48% in the SBE group.CONCLUSIONS:The complete enteroscopy rate was three times higher with DBE than with SBE, accompanied by a higher diagnostic yield. DBE must therefore continue to be regarded as the nonsurgical gold standard procedure for deep small-bowel endoscopy.


Gastrointestinal Endoscopy | 1998

Transmural drainage of pancreatic fluid collections without electrocautery using the Seldinger technique

Klaus Mönkemüller; Todd H. Baron; Desiree E. Morgan

BACKGROUND Complications of endoscopic transmural drainage of pancreatic fluid collections arise from entry through the gastrointestinal wall. We describe transmural drainage of these collections using the Seldinger technique without electrocautery. METHODS From January 1995 to September 1997, we attempted endoscopic transmural drainage of 94 consecutive pancreatic fluid collections without EUS guidance (needle-knife entry in 51, Seldinger entry technique in 43). Success of entry and complications were compared. RESULTS Successful entry was achieved in 95.3% using the Seldinger technique and 92.1% using the needle-knife entry technique (p = NS). Complications of bleeding and perforation were seen in 4.6% of patients in the Seldinger group and 15.7% in the needle-knife entry group. CONCLUSIONS The Seldinger technique of endoscopic transmural drainage of pancreatic fluid collections appears effective and safer than entry using the needle-knife. Collections as small as 3 cm in diameter can be entered using the Seldinger technique without EUS guidance.


The American Journal of Gastroenterology | 2000

Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.

Klaus Mönkemüller; Stephanie Call; Audrey J. Lazenby; Charles M. Wilcox

OBJECTIVE:Opportunistic disorders (OD) are the most frequent GI manifestations of the acquired immunodeficiency syndrome (AIDS). Since the introduction of highly active antiretroviral therapy (HAART), there appears to be have been a reduction in the incidence of many of these OD; however, the effect of HAART on the prevalence of GI OD has not been well studied.METHODS:From 4/95 through 3/98, all HIV (HIV)-infected patients undergoing GI endoscopy were prospectively identified; mucosal biopsies were obtained in a standardized fashion and histological specimens were examined by a single GI pathologist. Patients were divided into three groups based on the time of evaluation: group I: 4/95 to 3/96; group II: 4/96 to 3/97; and group III: 4/97 to 3/98.RESULTS:A total of 166 patients (90% men; mean age 36 ± 10 yr; median CD4 lymphocyte count 62 cells/μl, range 2–884, median viral RNA level 1,357 copies/ml, range undetectable to 7,721,715) underwent 279 upper and/or lower endoscopies during the study period. There were no statistical differences in patients’ demographics and indications for endoscopy although the CD 4 lymphocyte count was higher in group III. The percentage of patients receiving HAART at the time of endoscopy increased from 0% to 57% over the three periods (p < 0.01), and the percentage of patient receiving combination antiretroviral therapy increased from 37% to 82% over the study period (p < 0.01). In contrast, the prevalence of OD decreased from 69% (group I) to 13% (group III) (p < 0.01), whereas the prevalence of non-OD, including a normal endoscopy increased from 31% to 87% (p < 0.01).CONCLUSIONS:GI OD now seem to be an uncommon problem in HIV-infected patients undergoing endoscopy despite a low CD4 lymphocyte count, and this reduction of OD was associated with the use of HAART.


Gastrointestinal Endoscopy | 2015

SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Loren Laine; Tonya Kaltenbach; Alan N. Barkun; Kenneth R. McQuaid; Venkataraman Subramanian; Roy Soetikno; James E. East; Francis A. Farraye; Brian G. Feagan; John P. A. Ioannidis; Ralf Kiesslich; Michael J. Krier; Takayuki Matsumoto; Robert P. McCabe; Klaus Mönkemüller; Robert D. Odze; Michael F. Picco; David T. Rubin; Michele Rubin; Carlos A. Rubio; Matthew D. Rutter; Andres Sanchez-Yague; Silvia Sanduleanu; Amandeep K. Shergill; Thomas A. Ullman; Fernando S. Velayos; Douglas Yakich; Yu-Xiao Yang

Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; Veterans Affairs Palo Alto Healthcare System and Stanford University School of Medicine (affiliate), Palo Alto, California; Division of Gastroenterology, McGill University, Montreal, Quebec, Canada; University of California at San Francisco, Veterans Affairs Medical Center, San Francisco, California; University of Leeds, Leeds, United Kingdom


Alimentary Pharmacology & Therapeutics | 2009

Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding

Lucia C. Fry; Michael Bellutti; H Neumann; Peter Malfertheiner; Klaus Mönkemüller

Background  Double‐balloon enteroscopy (DBE) is a useful method for evaluation of obscure gastrointestinal bleeding (OGIB).


Gastrointestinal Endoscopy | 2008

Therapeutic ERCP with the double-balloon enteroscope in patients with Roux-en-Y anastomosis

Klaus Mönkemüller; Michael Bellutti; H Neumann; Peter Malfertheiner

1. Kucik CJ, Martin GL, Sortor BV. Common intestinal parasites. Am Fam Physician 2004;69:1161-8. 2. Bungiro R, Capello M. Hookworm infection: new developments and prospects for control. Curr Opin Infect Dis 2004;17:421-6. 3. Fulmer HS, Huempfner HR. Intestinal helminthes in eastern Kentucky: a survey in three rural counties. Am J Trop Med Hyg 1965;14: 269-75. 4. Weller PF, Nutman TB. Intestinal nematodes. In: Braunwald E, Fauci AS, Kasper DL, editors. Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw-Hill Companies, Inc; 2001. p. 1235. 5. Salata RA, editors. Intestinal nematodes. Textbook of Internal Medicine. 3rd ed. Philadelphia: Lipincott-Raven Publishers Philadelphia: 1997. p. 1832-3. 6. Loukas A, Bethony J, Brooker S, et al. Hookworm vaccines: past, present, and future. Lancet Infect Dis 2006;6:733-41.


Endoscopy | 2014

ERCP with the overtube-assisted enteroscopy technique: a systematic review

Matthew J. Skinner; Daniel Popa; Helmut Neumann; Charles M. Wilcox; Klaus Mönkemüller

BACKGROUND AND STUDY AIM Overtube-assisted enteroscopy (OAE) techniques have increased the ability to perform endoscopic retrograde cholangiopancreatography (ERCP) in patients with altered upper gastrointestinal anatomy, such as Roux-en-Y gastric bypass. The aim of this study was to compare the efficacy and safety of OAE-ERCP in patients with different configurations of upper gastrointestinal anatomy. PATIENTS AND METHODS A systematic review was performed following a literature search for papers published between 1966 and August 2013. The following databases were searched: MEDLINE (via PubMed), Embase, Cochrane library, and Scopus. The following end points were analyzed: diagnostic and therapeutic success rates, cannulation success rate, ERCP success rate, type of enteroscopy, types of intervention, complications. RESULTS A total of 23 relevant reports on OAE procedures, including single-balloon, double-balloon, and spiral enteroscopy, were analyzed. Studies included a total of 945 procedures in 679 patients (age 2 - 91 years) who had a variety of postsurgical upper gastrointestinal anatomical configurations. Among patients who underwent Roux-en-Y with gastric bypass, endoscopic success was 80 % and ERCP success was 70 %. In patients who had undergone a Roux-en-Y with either a pancreaticoduodenectomy, pylorus-preserving pancreaticoduodenectomy, or hepaticojejunostomy, endoscopic success was 85 % and ERCP success was 76 %. In patients who had undergone a Billroth II procedure, endoscopic success was 96 % and ERCP success was 90 %. In patients with native papilla who underwent successful endoscopy, cannulation was successful in 90 % of patients compared with 92 % in patients with an anastomosis. Overall ERCP success for all attempts was approximately 74 %. Interventions included sphincterotomy, pre-cut papillotomy, anastomotic stricturoplasty, stone removal, stent insertion, stent replacement, and balloon dilation of stenotic anastomosis. There were 32 major complications among the 945 procedures (3.4 %). CONCLUSION Both endoscopic and ERCP success rates were highest in patients with Billroth II anatomy, followed by those with pancreaticoduodenectomy and Roux-en-Y hepaticojejunostomy; the lowest success rates were in patients with Roux-en-Y gastric bypass. Cannulation rates appeared to be equivalent in patients with both native papilla and biliary-enteric or pancreaticoenteric anastomoses. The diagnostic and therapeutic potential of balloon-assisted ERCP were high and the adverse event rate was low.


Digestion | 2009

Endoscopic Retrograde Cholangiopancreatography Using the Single Balloon Enteroscope Technique in Patients with Roux-en-Y Anastomosis

Helmut Neumann; Lucia C. Fry; Frank Meyer; Peter Malfertheiner; Klaus Mönkemüller

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is technically challenging or impossible in patients with complex postsurgical anatomy. The aim of this cohort study was to assess the technical success of ERCP with the single balloon enteroscope (SBE) in patients with Roux-en-Y anastomosis. Patients: Patients with Roux-en-Y anastomosis presenting with cholestasis undergoing ERCP with the SBE technique in a tertiary university hospital. Diagnostic success was defined as successful duct cannulation or securing the diagnosis and therapeutic success was defined as the ability to successfully accomplish endoscopic therapy. Results: ERCP using the SBE was performed on 17 occasions in 13 patients (5 F, 8 M, mean age 66.5 years, range 25–77) with Roux-en-Y anastomosis. Indications for ERCP were biliary obstruction with common bile duct stones and/or cholangitis in all patients. The diagnostic success was 61.5% and the therapeutic success was 53.8%. Therapeutic interventions included dilation of common bile duct stenosis with a balloon (n = 4), biliary stent insertion (n = 2), removal of bile duct stones (n = 2), stent retrieval (n = 2), papillectomy (n = 1), and sphincterotomy (n = 1). No major complications occurred. Conclusions: ERCP using the SBE is feasible in patients with altered postsurgical anatomy presenting with biliary problems permitting diagnostic and therapeutic interventions.


The American Journal of Gastroenterology | 2004

Patterns of Bleeding after Endoscopic Sphincterotomy, the Subsequent Risk of Bleeding, and the Role of Epinephrine Injection

C. Mel Wilcox; Jerrold Canakis; Klaus Mönkemüller; Anthony Bondora; Wilma Geels

BACKGROUND:The patterns of bleeding following endoscopic sphincterotomy (ES) and their predictive value for subsequent bleeding are poorly understood. Similarly, the efficacy and side effects of epinephrine (E) injection for persistent bleeding have not been well studied.METHODS:Over a 44-month period, all patients undergoing ES were prospectively assessed and followed-up. The character of bleeding (pulsatile, oozing, trickle, none) was recorded immediately, 5 minutes following ES and at the completion of the procedure. Patients with persistent bleeding at the time the procedure was completed (5 minutes or greater) received E injection(s) (1:10,000 concentrations) into the bleeding point with a sclerotherapy needle. ES was performed in all patients with a single electrosurgical generator Valleylab (Force 1B) using pure cutting current.RESULTS:506 patients (68% females, mean age 54 years) who underwent 550 ES were studied. Bleeding patterns immediately following ES were: 6% pulsatile, 42% oozing, 27% trickle, and 24% none. E (median 0.5 cc; range 0.5–4 cc total) was injected during 79 procedures (14%); none of these patients had complications nor delayed bleeding. For all patients, delayed bleeding occurred in 8 (1.6%, 95% CI 0.57–0.0269); of these 8 delayed bleeders, 1 had no bleeding after ES, and only 1 had any bleeding at 5 minutes. The only variable associated with bleeding after ES was abnormal labs (thrombocytopenia, elevated creatinine concentration, hypoprothrombinemia).CONCLUSIONS:The pattern of bleeding following ES may not predict the risk of late bleeding. Abnormal labs are associated with visible bleeding. Epinephrine injection is safe and appears to provide effective hemostasis.

Collaboration


Dive into the Klaus Mönkemüller's collaboration.

Top Co-Authors

Avatar

Peter Malfertheiner

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

Helmut Neumann

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

L. C. Fry

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H Neumann

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

C. Mel Wilcox

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Vieth

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

Steffen Rickes

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

Doerthe Kuester

Otto-von-Guericke University Magdeburg

View shared research outputs
Researchain Logo
Decentralizing Knowledge